GreenLight Biosciences Launches Norroa, RNA Treatment for Varroa Mites
EPA registration paves the way for beekeepers to combat a critical threat to pollinator health GreenLight Biosciences (“the Company” or “GreenLight Bio”) today announced the...
Category : Public Health, Disease Prevention & Wellness
SFI Health, Curasense Partner on Equazen® for Dutch and Belgian Markets
– Partner Curasense will market Equazen® products featuring a clinically researched combination of essential fatty acids across pharmacies, healthcare stores and online pharmacies. SFI Health™ EMEA, the...
Corstasis, U.S. Heart & Vascular to Advance ENBUMYST™ for Heart Failure
The collaboration will seek to foster the adoption of appropriate protocols and pathways for the integration of ENBUMYST™ (bumetanide nasal spray) into clinical care with the goal...
Health Net Aids Members Affected by TCU Fires in California
Following Gov. Newsom’s declaration of a State of Emergency in Tuolumne County, Health Net, one of California’s most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE: CNC), is...
Leqembi® Approved in Australia for Early Alzheimer’s Treatment
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) announced today that the Therapeutic Goods Administration (TGA) of Australia has approved lecanemab (Leqembi) for the treatment of adult patients with mild...
SynGenSys Launches NK.SET Library for NK Cell Therapy Advances
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced...
Lucet Launches Lucet™ at Home, Integrates Emcara Health Brand
Unified Brand and Lucet™ at Home Reflects the Integration of Lucet and Emcara Health and a Shared Commitment to Expanding Access and Improving Clinical Outcomes. Lucet,...
Incyte Gets FDA Nod for Opzelura® Cream in Kids 2-11 with Eczema
Incyte (Nasdaq: INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura® (ruxolitinib) cream 1.5%, a topical Janus kinase (JAK) inhibitor, for...
Advancing Cancer Research Brings New Hope to Patients Worldwide
NetworkNewsWire Editorial Coverage Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical necessity. Deadly cancers such as glioblastoma...
Oscar Health Launches Convertible Notes Offering to Scale Growth
Oscar Health, Inc. (“Oscar”) (NYSE: OSCR) today announced its intention to offer, subject to market and other conditions, $350,000,000 aggregate principal amount of convertible senior...
AI Scams Named Medicare Fraud of the Month by NY Senior Council
The New York StateWide Senior Action Council (StateWide), a 53-year-old non-profit organization dedicated to serving the needs and well-being of our State’s more than 3.6...
Armor Expands Erie County Prison Care to Mental Health & Addiction
The Erie County Prison and their correctional healthcare partner, Armor Health (ArmorHealthcare.com), are pleased to announce the expansion of Medical services to include Mental Health...
SK bioscience Submits IND for Phase 3 Varicella Vaccine Trial
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has submitted an...
American Lung Assoc. Launches Support Program for Pulmonary Fibrosis
September is Pulmonary Fibrosis Awareness Month, and the American Lung Association today announced a new educational program to help people living with pulmonary fibrosis (PF) and their loved ones...
Starlight Foundation Launches Stream For Starlight Fundraiser
This September, in recognition of Childhood Cancer Awareness Month and Sickle Cell Awareness Month, Starlight Children’s Foundation is proud to announce this year’s Stream For Starlight campaign. Running from August 29...